Amarin Corp Plc (AMRN)

[KCSVEN]

I would say it still needs a Phase 3 and then FDA approval which likely puts it near REDUCE IT results time.(Within a year at least) Besides the fact they don;t have results to compare to Anchor or Marine yet.

I don't think there is any drug in testing that will be approved for Anchor population far enough ahead of Reduce It to make any dent in AMRN sales and none of those possible competitor drugs have even started a Reduce It trial. Since its expensive and 5-6 years to run AMRN is likely assured 5-6 years of Reduce IT related monopoly.

Even IF another drug comes along with better Trig and cholesterol details, IF Reduce It is successful Vascepa will lose almost no sales to that new drug.

If Reduce It Proves it reduces heart events, the other drugs will not have that proof. Doctors will prescribe the drug with an outcome study.

So I find little to be concerned in regard to ANY competition since Reduce It results will be known before anyone can really sell there product.

If Reduce It hits-Jackpot
If it fails-Disaster.
Anchor will be AMRN's territory alone for several years.

That's pretty much it.